MedTrace Logo

Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

NCT02959996 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-08-27

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Liposomal bupivacaine

liposomal bupivacaine injection in the Pfannenstiel incision

DRUG

Placebo

placebo injection in the Pfannenstiel incision

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • William H Barth, Jr, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2017-09-25
Completion
2017-11-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959996 on ClinicalTrials.gov